Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02298504 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Vital Pulp Treatment in Primary Teeth

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Primary and study completion dates: Dec 2025 to Dec 1, 2026v13
  2. Notable Primary and study completion dates: Feb 2025 to Dec 2025v12
  3. Minor Re-verified, no change to tracked fieldsv11
  4. Notable Enrollment target: 156 to 76
    • Primary and study completion dates: Jan 2024 to Feb 2025
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v10
  5. Notable Primary and study completion dates: Jan 2023 to Jan 2024v9
Show 7 earlier versionsHide 7 earlier versions
  1. Notable Primary and study completion dates: Jan 2022 to Jan 2023v8
  2. Minor Re-verified, no change to tracked fieldsv7
  3. Notable Primary and study completion dates: Jan 2020 to Jan 2022
    • Start date: Nov 2015 to Jul 1, 2018
    • Interventions: Biodentin (Drug), Mineral Trioxide Aggregate (Drug), Vitrebond (Drug) to Biodentin (Drug), Mineral Trioxide Aggregate (Drug), Vitrebond (Device)
    v6
  4. Notable Primary completion date: Jan 2019 to Jan 2020v5
  5. Minor Re-verified, no change to tracked fieldsv4
  6. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Jan 2018 to Jan 2019
    • Start date: Jun 2015 to Nov 2015
    • Study completion date: Jan 2020
    v3
  7. Notable Start date: Jan 2015 to Jun 2015v2
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In primary teeth, decay that is near the pulp (tooth nerve)is treated with either a pulpotomy or indirect pulp treatment if the tooth is not going to be extracted A pulpotomy involves removing the top 1/2 of the pulp, placing a medication/material on the pulp, covering the remaining pulp with a cement, and the restoring the tooth. The purpose of this pilot study is to gain preliminary information regarding the success of Biodentine, MTA, and IPT in the treatment of deep decay in children's primary molars.
Trial Details
NCT Number NCT02298504
Lead Sponsor University of Maryland, Baltimore
Conditions
(from sponsor)
Vital Pulp Therapies, Indirect Pulp Cap, Pulpotomy
Enrollment 76 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov